Authored By: Sarah
11 Jan 2022

Kidney Stones Market | Leading Segments, Trends, Drivers and Challenges

Market Recovery and Growth Projections 2022-2026

The kidney stones market is expected to grow by $ 416.09 mn, accelerating at a CAGR of almost 6.69% during the forecast period. Technavio’s research reports offer a detailed analysis of the market segments, delving deep into the factors that will lead to the growth of each segment. It also offers insights that are likely to have a negative impact on market growth. This comprehensive analysis of the market will enable clients to identify areas of growth and steer clear of the low-performing segments.


Request for Our Free Sample Report for detailed Insights


Kidney Stones Market Size to Grow by $ 416.09 mn through 2022-2026 | Leading Segments and Market Trends

Kidney Stones Market: Market Segments and Growth Forecasts

This research report will provide insights into the current market share of each segment along with growth projections for the next five years.

  • Market is segmented by Type (Thiazide diuretic, Pain relievers, Antibiotics, and Others) and Geography (North America, Europe, Asia, and ROW).
  • 40% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Kidney Stones Market size.

Kidney Stones Market Size to Grow by $ 416.09 mn through 2022-2026 | Leading Segments and Market Trends

Kidney Stones Market: Trends, Drivers, Challenges

The report also offers a detailed impact analysis of various trends, drivers, and challenges that are likely to influence the market growth during the forecast period. These insights will equip clients to design a growth strategy for their business and area of operations.

  • Growing popularity of digital flexible ureteroscopes will be a significant factor in driving the growth of the Kidney Stones Market.
  • Rising incidence of urolithiasis will be instrumental in driving the market growth during the forecast period.
  • Decreasing number of urologists coupled with a shortage of skilled surgeons is a hurdle that needs to be crossed on the path to success.

Kidney Stones Market: Vendor Analysis

  • The market is fragmented.
  • Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr. Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., and Pfizer Inc. are some of the major market participants.
  • The unprecedented outbreak of COVID-19 in 2020 has had a significant impact on market segments had a ripple effect on various stakeholders. Our vendor analysis and insights will provide you with all the information required to make the most of the opportunities and plan business recovery and growth post the pandemic.

Key Areas Covered in our Report:

  • Kidney Stones Market Split by Type
    • Thiazide diuretic
    • Pain relievers
    • Antibiotics
    • Others
  • Kidney Stones Market Split by Geography
    • North America
    • Europe
    • Asia
    • ROW

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • APAC - Market size and forecast 2020-2025
  • MEA - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • North America - Market size and forecast 2020-2025
  • South America - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive scenario
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Aristo Pharma GmbH
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Inc.
  • Dr. Reddys Laboratories Ltd.
  • Emcure Pharmaceuticals Ltd.
  • GlaxoSmithKline Plc
  • Intas Pharmaceuticals Ltd.
  • Macleods Pharmaceuticals Ltd.
  • Pfizer Inc.

For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market will accelerate at a CAGR of 6.69%.

     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 416.09 mn through 2022-2026.

     
  3. What is a key factor driving this market?
    Growing popularity of digital flexible ureteroscopes will drive market growth over the forecast period.

     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and ROW are the key regions featured in this research report.

     
  5. Which is the leading geographic region for this market:
    40% growth will originate from North America

     
  6. Who are the leading market vendors?
    The leading vendors in this market are Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr. Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., and Pfizer Inc.

     
  7. What are the market segments covered in this report?
    The market is segmented by Type (Thiazide diuretic, Pain relievers, Antibiotics, and Others) and Geography (North America, Europe, Asia, and ROW)
Read News Read Less
Interested in this report?
Get your sample now!
Technavio